| 12122761 |
2-azaspiro[3.4]octane derivatives as M4 agonists |
Amy Calhoun, Xin Chen, Kevin Matthew Gardinier, Keith Jendza, Nancy LABBE-GIGUERE +7 more |
2024-10-22 |
| 11820778 |
2-azaspiro[3.4]octane derivatives as M4 agonists |
Amy Calhoun, Xin Chen, Kevin Matthew Gardinier, Keith Jendza, Nancy LABBE-GIGUERE +7 more |
2023-11-21 |
| 11548865 |
2-azaspiro[3.4]octane derivatives as M4 agonists |
Amy Calhoun, Xin Chen, Kevin Matthew Gardinier, Keith Jendza, Nancy LABBE-GIGUERE +7 more |
2023-01-10 |
| 11485742 |
2-azaspiro[3.4]octane derivatives as M4 agonists |
Amy Calhoun, Xin Chen, Kevin Matthew Gardinier, Keith Jendza, Nancy LABBE-GIGUERE +7 more |
2022-11-01 |
| 11389541 |
Sustained delivery of angiopoetin-like 3 polypeptides |
Christopher M. Adams, Myriam APRIL, Tanzina Fazal, Cornelia Forster, Nicole GERWIN +2 more |
2022-07-19 |
| 10751417 |
Sustained release delivery systems comprising traceless linkers |
Christopher M. Adams, Myriam APRIL, Tanzina Fazal, Cornelia Forster, Cameron Chuck-munn Lee |
2020-08-25 |
| 10112926 |
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors |
Benjamin Richard Bellenie, Graham Charles Bloomfield, Ian Bruce, Andrew James Culshaw, Gregory John Hollingworth +3 more |
2018-10-30 |
| 10004732 |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
Benjamin Richard Bellenie, Graham Charles Bloomfield, Ian Bruce, Andrew James Culshaw, Gregory John Hollingworth +3 more |
2018-06-26 |
| 9034879 |
Heterocyclic compounds for the treatment of CF |
Kamlesh Jagdis Bala, Rebecca Butler, Stephen Paul Collingwood, Lee Edwards, Darren Mark Legrand +1 more |
2015-05-19 |